- Title: Subtitle
- Concurrent Durvalumab And Radiation Therapy (DUART) followed by Adjuvant Durvalumab in Patients with Localized Urothelial Cancer of Bladder: BTCRC-GU15-023
- Creators
- M. Joshi - Penn State Milton S. Hershey Medical CenterY. Zakharia - University of IowaM. Kaag - Penn State Milton S. Hershey Medical CenterD. Kilari - Medical College of WisconsinS. Holder - Penn State Milton S. Hershey Medical CenterH. Emamekhoo - University of Wisconsin Carbone Cancer CenterA. Sankin - Montefiore Medical CenterJ. Liao - Penn State Milton S. Hershey Medical CenterS. Merrill - Penn State Milton S. Hershey Medical CenterD. DeGraff - Pennsylvania State UniversityH. Zheng - Penn State Milton S. Hershey Medical CenterJ. Warrick - Pennsylvania State UniversityR. Hauke - Nebraska Cancer SpecialistsB. Gartrell - Montefiore Medical CenterM. Stein - Columbia UniversityJ. Drabick - Penn State Milton S. Hershey Medical CenterL.C. Tuanquin - Penn State Milton S. Hershey Medical Center
- Resource Type
- Abstract
- Publication Details
- International journal of radiation oncology, biology, physics, Vol.108(3 Supplement), pp.S29-S30
- Publisher
- Elsevier Inc
- DOI
- 10.1016/j.ijrobp.2020.07.2124
- ISSN
- 0360-3016
- eISSN
- 1879-355X
- Language
- English
- Date published
- 11/01/2020
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
- Record Identifier
- 9984548381902771
Abstract
Concurrent Durvalumab And Radiation Therapy (DUART) followed by Adjuvant Durvalumab in Patients with Localized Urothelial Cancer of Bladder: BTCRC-GU15-023
International journal of radiation oncology, biology, physics, Vol.108(3 Supplement), pp.S29-S30
11/01/2020
DOI: 10.1016/j.ijrobp.2020.07.2124
Details
Metrics
1 Record Views